Back to Search
MIN-FU TSAN, M.D., PH.D.
M.D., PH.D.
Hematology (Internal Medicine) Physician
NPI: 1437301553Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
D0015411(MD)
Research & Publications (20)
Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors.
PMID 17621541·J Endotoxin Res·2007
6-review
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
PMID 19054673·Bioorg Med Chem Lett·2009
7-preclinical
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents.
PMID 18226901·Bioorg Med Chem Lett·2008
8-other
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.
PMID 18242088·Bioorg Med Chem Lett·2008
8-other
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
PMID 18796353·Bioorg Med Chem Lett·2008
8-other
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
PMID 18722768·Bioorg Med Chem Lett·2008
8-other
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.
PMID 18662878·Bioorg Med Chem Lett·2008
8-other
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.
PMID 18554907·Bioorg Med Chem Lett·2008
8-other
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
PMID 18487044·Bioorg Med Chem Lett·2008
7-preclinical
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.
PMID 18457949·Bioorg Med Chem Lett·2008
7-preclinical
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
PMID 18442904·Bioorg Med Chem Lett·2008
7-preclinical
The heat sensitivity of cytokine-inducing effect of lipopolysaccharide.
PMID 16720829·J Leukoc Biol·2006
7-preclinical
Induction of cytokines by heat shock proteins and concanavalin A in murine splenocytes.
PMID 16289961·Cytokine·2005
7-preclinical
Induction of cytokines by heat shock proteins and endotoxin in murine macrophages.
PMID 15094389·Biochem Biophys Res Commun·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 IRVING ST NW
WASHINGTON, DC 20422 - Phone
- (202) 745-8544
Quick Facts
- NPI
- 1437301553
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile